Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
about
Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosisAntibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.Delayed Sputum Conversion in TB-HIV Co-Infected Patients with Low Isoniazid and Rifampicin Concentrations.The utility of pharmacokinetic studies for the evaluation of exposure-response relationships for standard dose anti-tuberculosis drugs
P2860
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
@ast
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
@en
type
label
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
@ast
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
@en
prefLabel
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
@ast
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
@en
P2860
P50
P356
P1476
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
@en
P2093
Frederick Sirgel
Jotam G Pasipanodya
P2860
P304
P356
10.1093/CID/CIX158
P407
P50
P577
2017-02-16T00:00:00Z